Regulation of hypoxic response elements on the expression of vascular endothelial growth factor gene transfected to rat skeletal myoblasts under hypoxic environment

Abstract

The regulation of hypoxic response elements on the expression of vascular endothelial growth factor (VEGF) gene transfected to primary cultured rat skeletal myoblasts under hypoxic environment was investigated. pEGFP-C3-9HRE-CMV-VEGF vector was constructed with molecular biology technique and transfected to primary cultured rat skeletal myoblasts by lipofectamine in vitro. Gene expression of transfected myoblasts was detected by RT-PCR, Western blot and fluorescence microscope under different oxygen concentrations and different hypoxia time. The results showed that in hypoxia group, the VEGF gene bands were seen and with the decrease of oxygen concentrations and prolongation of hypoxia time, the expression of VEGF mRNA was obviously increased. Under hypoxic environment, the expression of VEGF protein in the transfected myoblasts was significantly increased. EGFP was expressed only under hypoxic environment but not under normoxic environment. It was concluded that hypoxia promoter could be constructed with HRE and regulate the expression of VEGF gene under hypoxic and normoxic environment, which could enhance the reliability of gene therapy.

Keywords

hypoxic response elements / vascular endothelial growth factor / skeletal myoblasts

References

[1] BeauchampJ. R., MorganJ. E., PagelC. N., et al.. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol, 1999, 144: 1113-1122

[2] RehfeldtC., WaltherK., AlbrechtE., et al.. Intrinsic properties of muscle satellite cells are changed in response to long-term selection of mice for different growth traits. Cell Tissue Res, 2002, 310: 339-348

[3] BoubakerA. R., DaussinP. A., MicallefJ. P., et al.. Changes in mass and performance in rabbit muscles after muscle damage with or without transplantation of primary satellite cells. Cell Transplant, 2002, 11: 169-180

[4] RenaultV., ThomellL. E., BrowneG., et al.. Human skeletal muscle satellite cells: aging, oxidative stress and the mitotic clock. Exp Gerontol, 2002, 37: 1229-1236

[5] MenacheP., HagegeA. A., ScorsinM., et al.. Myoblast transplantation for heart failure. Lancet, 2001, 357: 279

[6] MurryC. E., WisemanR. W., SchwartzS. M., et al.. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest, 1998, 28: 2512-2523

[7] El OakleyR. M., OoiO. C., BongsoA., et al.. Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart. Ann Thorac Surg, 2001, 71: 1724-1733

[8] TaylorD. A., AtkinsB. Z., HungspreugsP., et al.. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med, 1998, 4: 929-933

[9] LeeS. H., WolfP. L., EscuderoR.. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med, 2000, 342: 626-633

[10] HenryT. D., AnnexB. H., MckendallG. R., et al.. The VIVA trail: VEGF in ischemia for vascular angiogenesis. Circulation, 2003, 107: 1359-1363

[11] JennyB., HarrisonJ. A., BaetensD., et al.. Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas. J Pathol, 2006, 209: 34-43

[12] TaberneroJ.. The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents. Mol Cancer Res, 2007, 5: 203-220

[13] XiaJ. H., XieA. N., XuL., et al.. Culture of rat musclesatellite cell in vitro. Chin J Exp Surg (Chinese), 2005, 22(2): 214-215

[14] SiminiakT., KalmuckiP., KurpiszM.. Autologous skeletal myoblasts for myocardial regeneration. J Interv Cardiol, 2004, 17(6): 357-365

[15] RigatelliG., RossiniK., VindigniV., et al.. New perspectives in the treatment of damaged myocardium using autologous skeletal myoblasts. Cardiovasc Radiat Med, 2004, 5(2): 84-87

[16] ChodorowskaG., ChodorowskiJ., WysokinskiA.. Vascular endothelial growth factor (VEGF) in physiological and pathological conditions. Ann Univ Mariae Curie Sklodowska [Med], 2004, 59(2): 8-14

[17] ZicheM., MorbidelliL., ChoudhuriR., et al.. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest, 1997, 99: 2625-2634

[18] QuZ., BalkirL., van DeutekomJ. C., et al.. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol, 1998, 142: 1257-1267

[19] LeeR. J., SpringerM. L., Blanco-BoseW. E., et al.. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation, 2000, 102: 898-901

[20] HuangL. E., BunnH. F.. Hypoxia-inducible factor and its biomedical relevance. Bio Chem, 2003, 278: 19575-19578